ARCHIVES

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

September 25, 1998

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Studies On Diet Add To Information On Fiber, Fat, Meat

April 5, 1991